Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
503
Total raised
£3.8B
disclosed amounts
This month
£36.9M
raised so far
The Series B round was led by Intrepid Growth Partners and will support international expansion and product development.
"At Intrepid Growth Partners, we invest in transformative machine intelligence-driven solutions that address critical challenges, and Skin Analytics exemplifies this vision. Their technology is redefining early skin cancer detection, improving patient outcomes while reducing healthcare costs. We are excited to support their growth as they scale their impact globally."
The investment was backed by the GMC Life Sciences Fund By Praetura and NPIF II, Praetura Equity Finance.
"We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers."
Empirical Ventures led the financing for the Imperial College London spinout.
"This funding marks a pivotal moment for OSSTEC, enabling us to bring our groundbreaking technology to market with our team of surgeons and engage in strategic collaborations to improve patient outcomes. We’re at the exciting intersection of innovative technology, delivering value for surgeons and patients and high-growth markets—all combined to help more people stay active and pain-free for longer. We’re excited to take the next steps in scaling our impact and making a meaningful difference in patients’ lives and the wider healthcare ecosystem."
The funding will support the development of the Callavid drug-device combination for threatened miscarriage.
"this new product will be extremely welcomed by miscarriage patients. Pessary leakage is a recurring issue amongst my patients, causing acute anxiety and significant inconvenience during a very difficult time."
The oversubscribed funding round was led by Fuel Ventures to scale artificial intelligence software for National Health Service trusts.
"We are thrilled by the strong investor backing for our vision to fundamentally improve NHS servicedelivery. This £1.5 million investment allows us to scale our technology more rapidly, helping NHStrusts eliminate unnecessary administrative burden, reduce reliance on costly external providers, andcrucially, get patients the timely care they need. We’re dedicated to empowering hospitals withsolutions that make a real-world difference for patients and healthcare professionals alike."
